Agree Realty Corporation

Agree Realty Corporation

56.80
EUR
-2.40
(-4.05%)
1.69EPS
Feb 16Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.33
3.6
3.89
4
4.04
4.28
4.62
4.8
5.08
5.46
5.65
6.1
6.49
6.69
Basic EPS, GAAP
1.51
1.24
2.17
1.97
2.1
1.81
1.97
1.76
1.8
1.84
1.71
1.8
1.78
1.87
Free Cash Flow per Basic Share
2.26
2.35
2.48
2.7
2.98
2.91
3.12
2.76
3.69
4.6
4.11
4.27
4.55
4.59
Dividend per Share
1.6
1.71
1.83
1.84
2
2.11
2.22
2.24
2.93
2.9
3
3.08
3.14
3.2
Book Value per Share
19.46
20.16
21.86
26.1
29.31
32.92
37.07
42.06
45.49
49.39
49.98
49.74
50.79
52.83
Tangible Book Value per Share
17.59
17.45
18.15
20.76
23.01
25.46
29.53
34.17
36.06
40.53
41.49
41.68
42.45
43.84
Basic Weighted Avg Shares
13
15
18
23
28
32
41
52
67
79
95
101
111
116
Sales/Revenue/Turnover
44
54
70
92
112
137
187
249
339
430
537
617
718
780
Operating Margin (%)
58.41
57.71
57.33
56.44
56.46
54.93
54.78
52
52.19
49.75
48.32
48.29
48.29
48.43
Depreciation Expense
9
11
16
23
32
44
59
83
120
167
209
240
276
302
Net Income, GAAP
20
18
39
45
58
58
80
91
122
152
170
189
204
225
Effective Tax Rate (%)
- -
- -
- -
0.33
0.38
0.87
0.66
1.17
1.92
1.83
1.68
2.22
0.84
0.6
Profit Margin (%)
45.21
34.52
55.77
49.29
52.11
42.42
42.71
36.76
36.03
35.47
31.62
30.66
28.45
28.84
Working Capital
8
-2
-3
24
43
33
-5
-60
12
-11
-29
-31
-28
-23
LT Debt
158
222
317
431
550
748
899
1,254
1,721
1,977
2,448
2,832
3,355
3,892
Total Equity
292
356
454
686
911
1,238
1,692
2,526
3,419
4,630
5,200
5,511
6,271
6,520
Return on Invested Capital (%)
5.89
5.3
5.81
5.37
4.81
4.16
4.85
4.02
4.07
3.6
3.51
3.7
3.76
3.84
Return on Capital (%)
5.94
5.06
7.32
6.23
5.8
4.72
4.79
3.98
3.73
3.6
3.5
3.69
3.75
3.84
Return on Common Equity (%)
8.12
5.75
9.7
7.96
7.3
5.42
5.47
4.34
4.17
3.77
3.43
3.51
3.45
3.68

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
3,295
3,693
3,821
LT Finance Leases
60
62
71
Preferred Equity and Hybrid Capital
175
175
175
Shares Outstanding
120
120
120
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
143
161
152
Cash, Cash Equivalents & STI
16
25
13
Accounts Receivable, Net
122
130
131
Inventories
- -
- -
- -
Total Current Liabilities
172
186
175
Payables & Accruals
172
186
175
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
30.87%
20.57%
13.8%
Free Cash Flow
28.79%
30.9%
16.71%
Net Income, GAAP
18.56%
17.86%
8.01%
Sales/Revenue/Turnover
26.44%
23.89%
16.42%
Total Cash Common Dividend
27.15%
25.63%
12.2%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
149
153
154
161
617
2025
169
176
183
190
718
2026
201
205
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.43
0.53
0.42
0.42
1.8
2025
0.42
0.43
0.45
0.47
1.78
2026
0.5
0.44
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.76
0.77
0.77
0.78
3.08
2025
0.78
0.78
0.78
0.8
3.14
2026
0.81
0.81
- -
- -
- -

Company Description

CEO
Joel N. Agree
Full Time Employees
90
Sector
Finance
Industry
Real estate investment trusts
Address
32301 Woodward Avenue Royal Oak MI United States 48073
IPO Date
Apr 15, 1994
Business
Agree Realty Corporation (NYSE: ADC), a fully integrated, self-administered and self-managed real estate investment trust founded in 1971 and headquartered in Royal Oak, Michigan, acquires, develops, owns and manages single-tenant retail properties net leased on a long-term basis primarily to investment-grade national and regional omni-channel retailers including Walmart, Advance Auto Parts, Dollar General, AutoZone, Gerber Collision, CVS, Burlington, Dollar Tree, Best Buy, Academy Sports, and Academy Sports; as of September 30, 2025, the portfolio comprises 2,603 properties containing approximately 54 million square feet of gross leasable area located across all 50 U.S. states, with 67% of annualized base rents derived from investment-grade tenants and 10.9% from ground leases. The company operates through acquisition, ground-up development, and its Developer Funding Platform, targeting properties in 28 retail sectors with a focus on stable, fee-simple ownership and weighted-average lease terms exceeding 10 years. In 2024, Agree Realty executed $951 million in total real estate investments including $867 million in 242 acquisitions at a 7.5% weighted-average cap rate (73.3% investment-grade in Q4), raised approximately $1.1 billion in forward equity through public offerings and its at-the-market program, closed a $350 million 5.5-year delayed draw term loan in November 2025, and strengthened liquidity to over $2.0 billion with no material debt maturities until 2028; for 2025, it projects $1.1 billion to $1.3 billion in investment volume representing a 26% increase at the midpoint.

Company News

  • Agree Realty: The Selloff Has Created An Attractive Income Opportunity

  • Daiichi Sankyo Highlights Ongoing Progress Across Industry-Leading ADC Portfolio with New Research Updates at ESMO

  • BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead's TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer

  • Agree Realty: 3 Key Takeaways for Long-Term Investors

  • What Agree Realty (ADC) Said on Its Q3 Earnings Call

  • Agree Realty Corporation (ADC) Q3 2026 Earnings Call Transcript

  • Agree Realty: 7.3% Acquisitions, $75 Equity, And A $67 Stock

  • Agree Realty (ADC) Beats Q3 FFO and Revenue Estimates

  • Agree Realty Corporation Reports Third Quarter 2026 Results

  • What To Watch This REIT Earnings Season

  • A $750,000 Dividend Portfolio Could Lose $13,920 a Year to Taxes. Here's the Roth Alternative

  • 3 Dividend Stocks That Let You Collect Rent Without Becoming a Landlord

  • Agree Realty Corporation After The Rate Hike: Buy, Hold, Or Sell?

  • Defence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform

  • ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast Cancer

  • /C O R R E C T I O N - AbbVie/

  • Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

  • AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio

  • Dividend Announcements: October 10-16, 2026

  • AI Reality Check, Inflation Stress Test